CoChat

Differential naltrexone antagonism of hydromorphone and pentazocine effects in human volunteers.

Preston, K L, Bigelow, G E · 1993 · The Journal of Pharmacology and Experimental Therapeutics
Cited by 61

The DOI matches its Crossref record.

Abstract

Naltrexone is more potent in blocking mu receptor activity than kappa receptor activity. This study examined the interactions of naltrexone with the mu agonist, hydromorphone, and with the mixed agonist-antagonist, pentazocine, to assess the apparent receptor mechanisms of their effects. After oral, 2-hr pretreatment with placebo or naltrexone (12.5 or 25 mg), a within-session cumulative dosing procedure (four intramuscular injections at 1-hr intervals) was used to assess the effects of hydromorphone (0, 0.75, 1.5 and 3 mg) and pentazocine (0, 15, 30 and 60 mg) vs. saline placebo. Subjective, physiological and behavioral effects were studied in six substance abusers. Hydromorphone significantly increased ratings on subjective measures typical of mu agonists, increased blood pressure and heart rate and decreased pupil diameter and respiratory rate; pretreatment with naltrexone (12.5 and 25 mg) blocked these effects. Pentazocine produced mu-like subjective effects, miosis and increases in blood pressure and heart rate. Naltrexone (12.5 mg) pretreatment decreased the mu-like subjective effects and miosis produced by pentazocine but increased kappa-like effects such as ratings of bad effects and Addiction Research Center Inventory LSD scale scores. Naltrexone (25 mg) blocked both the mu-like and kappa-like subjective effects of pentazocine. There was incomplete blockade of the cardiovascular effects of pentazocine. Thus, differential blockade of mu-like and kappa-like opioid effects by naltrexone was demonstrated in human subjects. Furthermore, the results suggest that mu agonist activity may suppress kappa-like effects such a dysphoria.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0022-3565(25)10212-7

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 61

Metadata

Authors
Preston, K. L., & Bigelow, G. E.
Venue
The Journal of Pharmacology and Experimental Therapeutics
Publisher
Elsevier BV
Published
1993-02
Volume
264
Issue
2
Pages
813-823
ISSN
0022-3565 (ISSN-L)
OpenAlex
W2270666457
Cited by
61
References
0
FWCI
0.46
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Differential naltrexone antagonism of hydromorphone and pentazocine effects in human volunteers. https://app.cochat.ai/papers/10.1016/s0022-3565(25)10212-7
The paper
Preston, K. L., & Bigelow, G. E. (1993). Differential naltrexone antagonism of hydromorphone and pentazocine effects in human volunteers. The Journal of Pharmacology and Experimental Therapeutics. https://doi.org/10.1016/s0022-3565(25)10212-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.